OrbiMed Capital GP V LLC, 10% Owner at PMV Pharmaceuticals, Inc. (PMVP), sold 52,506 shares at $15.93 ($836K) on 2022-05-26, disclosed to the SEC on 2022-05-31.
Open-market sale of $836k PMVP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.93 | 26,253 | $418K | 50.0% |
| 2 | $15.93 | 26,253 | $418K | 50.0% |
| Total | $15.93 avg | 52,506 | $836K | 100% |
| Filing → |
| CRVS | SELL | 2021-09-22 | $13.5M | — | Filing → |
| ARPO | SELL | 2020-12-10 | $42K | — | Filing → |
| INSP | SELL | 2020-08-19 | $19.7M | — | Filing → |